Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ActIVe study of Voxelotor in SCD
NCT04400487Phase 4Completed
- Sponsor
- Pfizer
- Start
- Dec 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of voxelotor in sickle cell disease (SCD), sponsored by Pfizer. Started Dec 2020; status: completed.
02
Drugs
voxelotor
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT04400487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400487.